Results

Total Results: 1,257 records

Showing results for "safety".
Users also searched for: patient safety

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0365_10-28-2010.pdf
    January 01, 2010 - Indirect/media (location at time of exposure—degree of safety) 3.
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-criteria-qdr-protocol.pdf
    September 06, 2023 - access to care, affordable care, care coordination, effective treatment, healthy living, patient safety … disparities measurement, race equity, gender equity, geographic equity, quality of care measurement, patient safety
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-framework-protocol.pdf
    September 06, 2023 - to access to care, affordable care, care coordination, effective treatment, healthy living, patient safety … Furthermore, AHRQ has identified new priority areas1 of health and access to care, i.e., patient safety
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ehc-research-gaps-telehealth.pdf
    April 01, 2023 - Interventions • Studies to determine the optimal structure and safety for routine and alternative … depression, fear of partner, coercive control, self-efficacy, post-traumatic stress disorder, and safety
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/suicide-prevention_research.pdf
    October 01, 2016 - attention on the strength and limits of evidence from research studies about the effectiveness and safety … Program Asarnow, 201536 Educational/skill building (SAFETY Cognitive-Behavioral Family Treatment … Jail records Cooper, 200660 Logistic regression County Living in a county that offered a minimum safety … The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes … The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
    August 01, 2012 - What are the significant safety concerns associated with each treatment strategy (i.e., adverse drug … What are the significant safety concerns associated with each treatment strategy (i.e., adverse drug … What are the significant safety concerns associated with each treatment strategy (i.e., adverse drug … Table C summarizes the key findings for each KQ, including the modifiers of effectiveness and safety … In addition, the safety concerns or harms of these treatment strategies are underreported for women
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-3.pdf
    February 01, 2018 - Meta-analyses of safety data: a comparison of exact versus asymptotic methods. … Meta-analyses of safety data: a comparison of exact versus asymptotic methods.
  8. effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
    March 01, 2010 - The key informants felt that this safety analysis would be a reasonable thing to do, so we performed … KQ 6: In patients with CF, how are efficacy, effectiveness, safety, or adverse events impacted by rhGH … KQ 7: In patients with CF, how do the efficacy, effectiveness, safety, or adverse events of treatment … Key question 6: In patients with CF, how are efficacy, effectiveness, safety, or adverse events impacted … Key question 7: In patients with CF, how do the efficacy, effectiveness, safety, or adverse events of
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
    May 01, 2019 - Management of Infertility Evidence Summary Purpose of Review Evaluate the comparative effectiveness and safety … Different treatments also carry different safety risks. … What are the comparative safety and effectiveness of available treatment strategies for women with … What are the comparative safety and effectiveness of available treatment strategies for women with … What are the comparative safety and effectiveness of available treatment strategies for women with
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-bone-metastases.pdf
    February 01, 2017 - However, SBRT efficacy and safety data are derived from lower quality studies with variable exclusion … Practitioners should closely adhere to quality and safety considerations for SBRT delivery as described … Once again, practitioners should use existing ASTROwhite paper safety recommendations.14 In general, … ASTRO guidelines present scientific, health, and safety information and may reflect scientific or medical … Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy
  11. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-2007_executive.pdf
    January 01, 2007 - All the same issues noted for RA of short- and long-term risks and safety, as well as performance in … and observational studies is insufficient to draw conclusions about the comparative tolerability and safety … biologics that met our eligibility criteria;1-8 five of these were observational studies assessing the safetySafety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease
  12. effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - prescription on the Internet by a company in Boise, ID (ABC Nutriceuticals, Inc.), although information on safety … of other medications for this indication, the ease of oxytocin administration, and its favorable safety … hypothalamus, and nucleus accumbens.5-8 Based on these findings, clinical trials are examining oxytocin’s safety … Internet from at least one company, ABC Nutriceuticals, Inc., Boise, ID, although information on safety
  13. effectivehealthcare.ahrq.gov/sites/default/files/whitepaper3-lijmer02262010-2.pdf
    January 01, 2009 - In Phase I, the safety, tolerability and toxicity, pharmacodynamics, and pharmacokinetics of the new … limited numbers of human subjects to gather preliminary evidence regarding effectiveness and additional safety … Phase III refers to controlled clinical studies intended to provide a reasonable assurance of safety … studies performed once a technology has gained marketing approval; these studies address long-term safety
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-tests-proposals_research.pdf
    January 01, 2009 - In Phase I, the safety, tolerability and toxicity, pharmacodynamics, and pharmacokinetics of the new … limited numbers of human subjects to gather preliminary evidence regarding effectiveness and additional safety … Phase III refers to controlled clinical studies intended to provide a reasonable assurance of safety … studies performed once a technology has gained marketing approval; these studies address long-term safety
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/healthcare-infections_disposition-comments.pdf
    August 10, 2015 - In all of patient safety we need more rigorous conceptual frameworks that translate into models with … professionalism of environmental services personnel, and emphasized their central role in patient safety … Part of this is discussed in the section on patient safety culture (page 16 and following), but a key … KI Reviewer 3 Findings P23, L25 - The contents under the subheading “Patient Safety Culture” provide … A safety concern with improper use is airway and mucous membrane irritation.”
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-cancer_research-protocol.pdf
    August 10, 2016 - complexity of this decisionmaking process is a lack of clarity regarding the comparative efficacy and safety … clinicians, and payers to have reliable estimates of KC treatments’ comparative effectiveness and safety … this systematic review is to comprehensively collect information on the comparative effectiveness and safety … Comments About the Eligibility Criteria Because the key questions are about comparative effectiveness and safety
  17. effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/registry-of-patient-registries_research.pdf
    April 15, 2019 - , patient registries can provide unique insights into real-world clinical practice, effectiveness, safety … Food and Drug Administration (FDA) uses registries in assessing the safety and effectiveness of drugs … found that different definitions of bleeding “can lead to markedly different conclusions about the safety … Areas for measurement include (a) affordable care, (b) patient safety, (c) person- and family-centered … Common Formats for Patient Safety Data. 2014. http://www.qualityforum.org/ProjectDescription.aspx ?
  18. effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
    January 01, 2012 - These safety concerns may present barriers to approval or barriers to diffusion if approved. … determinations stated MSC therapy is investigational because of insufficient evidence or long-term safety … Both groups had similar safety profiles. 29 In a study of patients with knee OA (Outerbridge grades … (which has yet to be determined), but some of the experts expressed strong concerns regarding its safety … These safety concerns may present significant barriers to approval and diffusion if approved.
  19. effectivehealthcare.ahrq.gov/sites/default/files/devdelays_adhd_autism_hi_impact.pdf
    January 01, 2012 - injuries caused by HBOT, so the treatment is controversial not only on the basis of efficacy, but on safety … Comments: Experts commenting on this intervention expressed concern about the underlying theory and safety … impending severe emotional distress could be critical to more effective management and increased safety … The expert indicated the intervention may pose safety issues in patients with otitis media and asthma … Safety concerns, the closed environment of the HBOT chamber (which could cause claustrophobia), and
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
    March 05, 2015 - would strongly benefit from the statement on page ES- 11: No studies were identified examining the safety … Page ES-14 Research Gaps: “These agents are unregulated and safety data may be limited or absent.” … The authors’ actual conclusion was that the safety data ARE limited or absent, not that they may be … Their focus on the lack of evidence on compounded HT (safety and efficacy) being used by millions of … A review of evidence for all safety data for the nonhormonal agents was beyond the scope of the review

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: